The 2021 Alzheimer’s Disease Genetics Global Symposium: Pathway to Translation, supported by NIA and the Alzheimer’s Association, is open for registration. The conference will convene dementia researchers and clinicians to discuss how discoveries in genetics impact biomarker development and discovery and validation of potential treatment targets, and how to apply these findings in basic and translational research.
This no-cost virtual symposium includes on-demand webinars available in July to prepare viewers for a live discussion in September. Presenters will include Francis S. Collins, M.D., Ph.D., director of NIH; Maria Carrillo, Ph.D., chief science officer of the Alzheimer’s Association; and many others. Participants will be able to submit questions by Aug. 23 for the opportunity to have presenters answer them during the live Q&A.
Key dates:
- July 25: On-demand webinars available
- Aug. 23: Last day to submit questions for the live discussion
- Sept. 1: 11 a.m. to 1 p.m. EST: Live discussion
Learn more and register for the 2021 Alzheimer’s Disease Genetics Global Symposium.